McMoRan's strong financials, 2024 growth, and valuation insights. Learn about risks in Indonesia and if FCX is worth your ...

The pharma company currently has a market cap of Rs 92316 crore ... We categorically deny the claim of a 25 per cent workforce cost reduction and the other claims mentioned in the said news article," ...

Jabil has improved returns through operational efficiency and cost control. Its valuation indicates no margin of safety. See ...

Rights Mar 16, 2016 Mar 17, 2016 May 12, 2015 Rights ratio: 5 share for every 116 held at a price of Rs 245.0 Rights Aug 23, 2012-Jul 14, 2011 Rights ratio: 1 share for every 7 held at a price of Rs ...

Mankind Pharma Ltd., incorporated in the year 1991, is a Small Cap company (having a market cap of Rs 1,06,508.27 Crore) operating in Pharmaceuticals sector. Mankind Pharma Ltd. key Products/Revenue ...

NAARDEN, the Netherlands and MIAMI, April 17, 2025 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical ...

In the last 15 years, there has been a noticeable shift towards many prominent players effectively outsourcing innovation to start-ups due to the increasing cost of R&D. In 2018, over 60% of all ...

The pharma sector is likely to maintain steady earnings. Most brokerages flag US business recovery as the key swing factor ...

And it’s easy to see why – AI’s potential is staggering, with its adoption increasingly reflected in the KPIs of every major pharma company ... priorities? The cost of developing a new ...

Our cost of living calculator will help you figure out if your move will work for your budget and salary. Ideally, you’ll find that you can afford the cost of living in your new destination ...